October 2 CBPP Spotlight | Case-Based Peer Perspectives Spotlight Live

Evaluation of RESPONSE Trials Guides Use of Ruxolitinib in Polycythemia Vera

December 13, 2020

Clinical Articles

During a Targeted Oncology Case Based Peer Perspectives event, Andrew Kuykendall, MD, assistant member, Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, discussed the use of ruxolitinib as treatment of 67-year-old patients with polycythemia vera.